Briana R. De Miranda

LRRK2 activation in idiopathic Parkinson’s disease

Roberto Di Maio, Eric K. Hoffman, Emily M. Rocha et al. · Science Translational Medicine · 2018 · 580 citations · Full text

LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease

Emily M. Rocha, Briana R. De Miranda, Sandra L. Castro et al. · Neurobiology of Disease · 2019 · 98 citations · Full text

Mitophagy, Cell Death, Synaptic Signaling +25

Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease

Briana R. De Miranda, Emily M. Rocha, Qing Bai et al. · Neurobiology of Disease · 2018 · 94 citations · Full text

Rotenone-induced Neurotoxicity, Medicine, Cell Death +10

Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson’s Disease Incidence

Briana R. De Miranda, Marco Fazzari, Emily M. Rocha et al. · Toxicological Sciences · 2019 · 83 citations · Full text

Human Parkinson ’, Social Sciences, Neurobiology Of Disease +20

The Nurr1 Activator 1,1-Bis(3′-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB

Briana R. De Miranda, Katriana A. Popichak, Sean L. Hammond et al. · Molecular Pharmacology · 2015 · 75 citations · Full text